Synthesis and antimalarial evaluation of cyclic β-amino acid-containing dipeptides

Molecules

Volumn 13, Issue 2, 2008, Pages 432-443

  Sathe, Manisha ^a   Thavaselvam, Duraipandian ^b   Srivastava, Ashish Kumar ^a   Kaushik, Mahabir Parshad ^a  

^a Discovery Center   (India)

^b DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

amino acid; Lactam; Antimalarial; Plasmodium berghai; Plasmodium falciparum

Indexed keywords

AMINO ACID; ANTIMALARIAL AGENT; DIPEPTIDE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; IC 50; MOUSE; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; SCHIZONT; SYNTHESIS;

AMINO ACIDS, CYCLIC; ANIMALS; ANTIMALARIALS; DIPEPTIDES; DRUG RESISTANCE; HUMANS; INHIBITORY CONCENTRATION 50; MICE; PARASITIC SENSITIVITY TESTS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; SCHIZONTS;

EID: 40349096353     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules13020432     Document Type: Article

References (28)

1. (a) Wyler, D.J. Malaria: overview and update. Clin. Infect. Dis. 1993, 16, 449-456;
2. (b) Kano, S. Global malaria control into the 21st century Prog. Med. 2001, 21, 319-324;
3. (c) Greenwood, B.; Mutabingwa, T. Malaria in 2002. Nature 2002, 415, 670-672.
4. Ridley, R.G. Enhanced: planting the seeds of new antimalarial drugs. Science 1999, 285, 1502-1503.
5. Murray, M.C.; Perkin, M.E. The synthesis and testing of arenearylpyrimidylmethanes as antimalarial agents. Annu. Rep. Med. Chem. 1996, 31, 141-150.
6. Hyde, J.E. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microb. Inf. 2002, 4, 165-174.
7. Alisky, J.M., Chertkova, E.L., Iczkowski, K.A. Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis. Med. Hypoth. 2006, 67, 1090-1094.
8. (a) Cook, G.C. Fatal Stevens-Johnson syndrome associated with fansidar and chloroquine. J. Infect. 1987, 14, 92;
9. (b) Dua, V.K.; Sarin, R.; Sharma, V.P. Sulphadoxine concentrations in plasma, red blood cells and whole blood in healthy and Plasmodium falciparum malaria cases after treatment with Fansidar using high-performance liquid chromatography. J. Pharm. Bio. Med. Anal. 1994, 12, 1317-1323;
10. (c) Rombo, L.; Stenbeck, J.; Lobel, H.O.; Campbell, C.; Papaionou, M.; Miller, K. Does chloroquine contribute to the risk of serious adverse reactions to fansidar? Lancet 1985, 326, 1298-1299.
11. Werbovetz, K.A. Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis. Curr. Med. Chem. 2000, 7, 835-860.
12. Berry, C. Synthesis of plasmepsin II inhibitors-potential antimalarial agents. Curr. Opin. Drug Discovery Dev. 2003, 3, 624-629.
13. (a) Blackman, M.J. Proteases involved in erythrocyte invasion by the malaria parasite function and potential as chemotherapeutic targets. Curr. Drug Targets 2000, 1, 59-83;
14. (b) Francis, S. E.; Sullivan, D.J. Jr.; Goldberg, D.E. Hemoglobin metabolism in the malaria parasite plasmodium falciparum. Annu. Rev. Microbiol. 1997, 51, 97-123.
15. Haque, T.S., Skillman, A.G., Lee, C.E., Habashita, H., Gluzman, I.Y., Ewing, T.J.A, Goldberg, D.E., Kuntz, I.D., Ellman, J.A. Potent, low-molecular weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II. J. Med. Chem. 1999, 42, 1428-1440.
16. (a) Weiesner, J.; Ortmann, R.; Jomaa, H..; Schlitzer, M. New antimalarial drugs. Angew. Chem. Int Ed. 2003, 42, 5274-5293;
17. (b) Singh, S.B.; Zink, D.L.; Polishook, J.D.; Dombrowski, A. W.; Darkin-Rattray, S.J.; Schmatz, D.M.; Goetz, M.A. Apicidins: Novel cyclic tetrapeptides as coccidiostats and antimalarial agents from Fusarium pallidoroseum. Tetrahedron Lett.1996, 37, 8077-8080.
18. Thongtan, J.; Saenboonrueng, J.; Rachtawee, P.; Isaka, M. An Antimalarial Tetrapeptide from the Entomopathogenic Fungus Hirsutella sp. BCC 1528. J. Nat. Prod. 2006, 69, 713-714.
19. (a) Fulop, F. The chemistry of 2-aminocycloalkanecarboxylic acids. Chem. Rev. 2001, 101, 2181-2204;
20. (b) Fulop, F.; Martinek, T.A.; Toth, G.K. Application of alicyclic β-amino acids in peptide chemistry. Chem. Soc. Rev. 2006, 35, 323-334.
21. Knapp, S. Synthesis of complex nucleoside antibiotics. Chem. Rev. 1995, 95, 1859-1876.
22. (a) Cativiela, C.; Diaz-de-Villegas, M.D. Asymmetric synthesis of α-amino acids using polymer-supported Cinchona alkaloid-derived ammonium salts as chiral phase-transfer catalysts Tetrahedron Asymmetry 2000, 11, 645-732;
23. (b) Lambert, J.N.; Mitchell, J.P.; Roberts, K. The synthesis of cyclic peptides. J. Chem. Soc., Perkin Trans. 1 2001, 471-484.
24. (a) Parsons, P.J.; Camp, N.P.; Underwood, J.M.; Harvey, M.D. Tandem reactions of anions: A short and efficient route to ± Anatoxin-a. Tetrahedron, 1996, 52, 11637-11642;
25. (c) Szakonyi, Z.; Fulo, F.; Bernath, G.; Evanics, F.; Riddell, G. Synthesis and ring-chain tautomerism of angularly substituted cycloalkane-fused tetrahydro-1,3-oxazines. Tetrahedron, 1998, 54, 1013-1020;
26. (d) Szakonyi, Z.; Martinek, T.; Sillanpaeae, R.; Fulop, F. Regio- and stereoselective synthesis of the enantiomers of monoterpene-based beta-amino acid derivatives. Tetrahedron Asymmetry 2007, 18, 2442-2447;
27. (e) Sathe, M.; Ghorpade, R.; Kaushik, M.P. Highly efficient methanolysis of bicyclic β-lactams to β-amino ester using silica chloride. Chem. Lett. 2006, 35, 1004-1005.
28. Trager, W.; Jensen, J.B. Human malaria parasites in continuous culture. Science 1976, 193, 673-675.